Whereas no differences were observed when either unstimulated or non-antigenic-stimulated cells were analyzed, results showed that CD19+ cells expressing TNFα were significantly increased in patients with a diagnosis of either PP, SP and RR multiple sclerosis compared to BEMS individuals and HC, with the highest values being present in PPMS patients. This evidence concerns the gene TNF and primary progressive multiple sclerosis.